Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Paneth cell-like change in benign prostate can account for P504S (AMACR) reactivity.

Iczkowski KA.

Int J Clin Exp Pathol. 2014 May 15;7(6):3454-5. eCollection 2014.

PMID:
25031776
[PubMed - in process]
Free PMC Article
2.

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.

Becker JT, McNeel DG.

J Immunother Cancer. 2013 May 29;1:2. doi: 10.1186/2051-1426-1-2. eCollection 2013.

PMID:
24764533
[PubMed]
Free PMC Article
3.

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.

Lipianskaya J, Cohen A, Chen CJ, Hsia E, Squires J, Li Z, Zhang Y, Li W, Chen X, Xu H, Huang J.

Asian J Androl. 2014 Jul-Aug;16(4):541-4. doi: 10.4103/1008-682X.123669.

PMID:
24589459
[PubMed - in process]
Free PMC Article
4.

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.

Berruti A, Vignani F, Russo L, Bertaglia V, Tullio M, Tucci M, Poggio M, Dogliotti L.

Open Access J Urol. 2010 Jul 23;2:109-24. Review.

PMID:
24198620
[PubMed]
Free PMC Article
5.

The molecular basis for ethnic variation and histological subtype differences in prostate cancer.

Zong Y, Goldstein AS, Huang J.

Sci China Life Sci. 2013 Sep;56(9):780-7. doi: 10.1007/s11427-013-4522-0. Epub 2013 Jul 13. Review.

PMID:
23852643
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.

Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA.

Cancer Cell. 2013 Mar 18;23(3):332-46. doi: 10.1016/j.ccr.2013.02.016. Erratum in: Cancer Cell. 2013 Jun 10;23(6):853. Fazil, Ladan [corrected to Fazli, Ladan].

PMID:
23518348
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Neuroendocrine differentiation of prostate cancer.

Li Z, Chen CJ, Wang JK, Hsia E, Li W, Squires J, Sun Y, Huang J.

Asian J Androl. 2013 May;15(3):328-32. doi: 10.1038/aja.2013.7. Epub 2013 Mar 18. No abstract available.

PMID:
23503426
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.

Huang J, Wang JK, Sun Y.

Curr Opin Urol. 2013 May;23(3):189-93. doi: 10.1097/MOU.0b013e32835e9ef4. Review.

PMID:
23385974
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity.

Bonorden MJ, Grossmann ME, Ewing SA, Rogozina OP, Ray A, Nkhata KJ, Liao DJ, Grande JP, Cleary MP.

Prostate Cancer. 2012;2012:543970. doi: 10.1155/2012/543970. Epub 2012 Dec 4.

PMID:
23304522
[PubMed]
Free PMC Article
10.

Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.

Chen H, Sun Y, Wu C, Magyar CE, Li X, Cheng L, Yao JL, Shen S, Osunkoya AO, Liang C, Huang J.

Endocr Relat Cancer. 2012 May 24;19(3):321-31. doi: 10.1530/ERC-11-0368. Print 2012 Jun.

PMID:
22389383
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

PC3 is a cell line characteristic of prostatic small cell carcinoma.

Tai S, Sun Y, Squires JM, Zhang H, Oh WK, Liang CZ, Huang J.

Prostate. 2011 Nov;71(15):1668-79. doi: 10.1002/pros.21383. Epub 2011 Mar 22.

PMID:
21432867
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model.

Chang HH, Chen BY, Wu CY, Tsao ZJ, Chen YY, Chang CP, Yang CR, Lin DP.

J Biomed Sci. 2011 Jan 18;18:6. doi: 10.1186/1423-0127-18-6.

PMID:
21241512
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells.

Goldstein AS, Stoyanova T, Witte ON.

Mol Oncol. 2010 Oct;4(5):385-96. doi: 10.1016/j.molonc.2010.06.009. Epub 2010 Jul 14. Review.

PMID:
20688584
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Neuroendocrine differentiation in prostate cancer.

Sun Y, Niu J, Huang J.

Am J Transl Res. 2009 Feb 5;1(2):148-62.

PMID:
19956427
[PubMed]
Free PMC Article
15.

Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.

Sotomayor P, Godoy A, Smith GJ, Huss WJ.

Prostate. 2009 Mar 1;69(4):401-10. doi: 10.1002/pros.20895.

PMID:
19058139
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate.

Liu Y.

World J Surg Oncol. 2008 Jun 19;6:64. doi: 10.1186/1477-7819-6-64.

PMID:
18565231
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.

Huss WJ, Gray DR, Tavakoli K, Marmillion ME, Durham LE, Johnson MA, Greenberg NM, Smith GJ.

Neoplasia. 2007 Nov;9(11):938-50.

PMID:
18030362
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk